A number of different medications have emerged to treat HER2-positive breast cancer. In this video, learn about the types of targeted therapy to treat this subtype of breast cancer, according to Natalie Berger, MD, Hematologist and Oncologist at The Mount Sinai Hospital.
Natalie Berger, MD, served as a Hematologist and Oncologist at The Mount Sinai Hospital in New York City. She is currently an Assistant Professor of Medicine at Columbia University Irving Medical Center and Director of Breast Medical Oncology at NewYork-Presbyterian Medical Group Hudson Valley.
References
American Cancer Society. (2023). Targeted therapy for breast cancer.
National Cancer Institute. (n.d.). HER2/neu.
Swain, S. M., et al. (2022). Targeting HER2-positive breast cancer: Advances and future directions. Nature Reviews. Drug Discovery.
Why trust our experts?
